Synapticure is a Chicago-based tele-neurology company providing personalized care for patients and families affected by ALS (Amyotrophic Lateral Sclerosis), a progressive neurodegenerative disease that affects the nerve cells responsible for controlling voluntary muscles.
Through the company's tele-neurology platform, Synapticure's team of neurologists and healthcare professionals are able to remotely diagnose, monitor, and treat ALS patients, providing them with tailored healthcare plans and ongoing support. The company's approach aims to improve the quality of life for ALS patients and their families, by reducing the burden of in-person visits along with providing increased access to care.
With funding raised from several investment organizations, Synapticure is well-equipped to provide specialized care and support to ALS patients and their families, with the potential to make a significant impact on the management of ALS. Synapticure plans to utilize the capital it has gained to further scale its care platform to provide its services to people living with ALS across the United States.
Kirsty
Company Specialist at Welcome to the Jungle